Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency

Autor: Stylianos E. Antonarakis, William C. Nichols, David Ginsburg, Flora Peyvandi, Colette Rossier, Marguerite Neerman-Arbez, Edward G. D. Tuddenham, John H. McVey, Michael A. Morris, K. M. Johnson
Jazyk: angličtina
Rok vydání: 1999
Předmět:
Male
Candidate gene
DNA Mutational Analysis
Ethnic Groups/genetics
Algeria/ethnology
Factor V Deficiency/complications/ethnology/ genetics
Iran
Great Britain/ethnology
Biochemistry
Pakistan/ethnology
South Africa
Exon
Consanguinity
Jews/genetics
Membrane Proteins/deficiency/ genetics
Ethnicity
Pakistan
Italy/ethnology
Polymorphism
Single-Stranded Conformational

Genetics
ddc:616
Splice site mutation
biology
South Africa/ethnology
Factor V
Hematology
Italy
Allelic heterogeneity
Female
Factor V Deficiency
China
Hemophilia A/complications/ethnology/ genetics
Immunology
Locus (genetics)
Genes
Recessive

Hemophilia A
China/ethnology
Codon/genetics
Humans
Allele
Codon
Gene
Alleles
Membrane Proteins
Cell Biology
United Kingdom
Iran/ethnology
Mannose-Binding Lectins
Haplotypes
Algeria
Jews
Mutation
biology.protein
Zdroj: Blood, Vol. 93, No 7 (1999) pp. 2253-2260
Scopus-Elsevier
Europe PubMed Central
ISSN: 0006-4971
Popis: Combined factor V-factor VIII deficiency (F5F8D) is a rare, autosomal recessive coagulation disorder in which the levels of both coagulation factors V and VIII are diminished. The F5F8D locus was previously mapped to a 1-cM interval on chromosome 18q21. Mutations in a candidate gene in this region, ERGIC-53, were recently found to be associated with the coagulation defect in nine Jewish families. We performed single-strand conformation and sequence analysis of the ERGIC-53 gene in 35 F5F8D families of different ethnic origins. We identified 13 distinct mutations accounting for 52 of 70 mutant alleles. These were 3 splice site mutations, 6 insertions and deletions resulting in translational frameshifts, 3 nonsense codons, and elimination of the translation initiation codon. These mutations are predicted to result in synthesis of either a truncated protein product or no protein at all. This study revealed that F5F8D shows extensive allelic heterogeneity and all ERGIC-53 mutations resulting in F5F8D are “null.” Approximately 26% of the mutations have not been identified, suggesting that lesions in regulatory elements or severe abnormalities within the introns may be responsible for the disease in these individuals. In two such families, ERGIC-53 protein was detectable at normal levels in patients’ lymphocytes, raising the further possibility of defects at other genetic loci.
Databáze: OpenAIRE